[go: up one dir, main page]

DE60322395D1 - Antipruritisches mittel - Google Patents

Antipruritisches mittel

Info

Publication number
DE60322395D1
DE60322395D1 DE60322395T DE60322395T DE60322395D1 DE 60322395 D1 DE60322395 D1 DE 60322395D1 DE 60322395 T DE60322395 T DE 60322395T DE 60322395 T DE60322395 T DE 60322395T DE 60322395 D1 DE60322395 D1 DE 60322395D1
Authority
DE
Germany
Prior art keywords
antipruritive
agent
evoked
administering
prostaglandin derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60322395T
Other languages
English (en)
Inventor
Fumie Sato
Iwao Arai
Norikazu Takano
Tohru Tanami
Makoto Yagi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE60322395D1 publication Critical patent/DE60322395D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
DE60322395T 2002-08-09 2003-08-07 Antipruritisches mittel Expired - Lifetime DE60322395D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002234011 2002-08-09
PCT/JP2003/010051 WO2004014394A1 (ja) 2002-08-09 2003-08-07 止痒剤

Publications (1)

Publication Number Publication Date
DE60322395D1 true DE60322395D1 (de) 2008-09-04

Family

ID=31711882

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60322395T Expired - Lifetime DE60322395D1 (de) 2002-08-09 2003-08-07 Antipruritisches mittel

Country Status (18)

Country Link
US (1) US7718701B2 (de)
EP (1) EP1527781B1 (de)
JP (1) JP3678366B2 (de)
KR (1) KR100904583B1 (de)
CN (1) CN100408039C (de)
AT (1) ATE401895T1 (de)
AU (1) AU2003254850B2 (de)
CA (1) CA2465103C (de)
DE (1) DE60322395D1 (de)
DK (1) DK1527781T3 (de)
ES (1) ES2309380T3 (de)
HK (1) HK1076391A1 (de)
MX (1) MXPA04004371A (de)
NO (1) NO20042053L (de)
PL (1) PL373819A1 (de)
PT (1) PT1527781E (de)
TW (1) TW200404053A (de)
WO (1) WO2004014394A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040266880A1 (en) * 2002-02-22 2004-12-30 Fumie Sato Antipruritics
RU2311407C2 (ru) 2002-07-12 2007-11-27 Таисо Фармасьютикал Ко., Лтд Производное простагландина, фармацевтическая композиция
JP3678366B2 (ja) 2002-08-09 2005-08-03 大正製薬株式会社 止痒剤
US7737182B2 (en) * 2002-08-09 2010-06-15 Taisho Pharmaceutical Co., Ltd. Pharmaceuticals for xerosis
JPWO2006085655A1 (ja) * 2005-02-14 2008-06-26 大正製薬株式会社 軟膏剤
SI1944298T1 (sl) 2005-10-03 2013-05-31 Nippon Shinyaku Co., Ltd. Kinazolinski derivat in zdravilo
US20100016427A1 (en) * 2006-08-11 2010-01-21 Taishio Pharmaceutical Co., Ltd. External preparation comprising prostaglandin derivative
JPWO2009004873A1 (ja) * 2007-06-29 2010-08-26 大正製薬株式会社 プロスタグランジン誘導体含有水性液剤

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3126924A1 (de) * 1981-07-03 1983-01-20 Schering Ag, 1000 Berlin Und 4619 Bergkamen 9-fluor-prostaglandinderivate, verfahren zur herstellung und verwendung als arzneimittel
US4983629A (en) * 1983-07-08 1991-01-08 Schering Aktiengesellschaft 11-haloprostane derivatives, processes for their preparation and their use as medicinal agents
DE3325175A1 (de) * 1983-07-08 1985-01-17 Schering AG, 1000 Berlin und 4709 Bergkamen 11-halogen-prostanderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3347128A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 9-halogen-(delta)(pfeil hoch)2(pfeil hoch)-prostaglandinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
CA1322197C (en) * 1987-07-17 1993-09-14 Bernd Buchmann 9-halogen-(z) prostaglandin derivatives, process for their production and their use as pharmaceutical agents
US5891910A (en) * 1987-07-17 1999-04-06 Schering Aktiengesellschaft 9-halogen-(Z) prostaglandin derivatives, process for their production and their use as pharmaceutical agents
US5591446A (en) * 1989-04-04 1997-01-07 Beiersdorf, A.G. Methods and agents for the prophylaxis of atopy
US5252602A (en) 1991-10-11 1993-10-12 Rafeul Alam Effects of misoprostol on allergic responses
US5403867A (en) * 1992-02-07 1995-04-04 Kaken Pharmaceutical Co., Ltd. Preparation for treating wounds or hemorrhoids
AU664915B2 (en) 1992-07-24 1995-12-07 Fumie Sato Prostaglandin derivative
CA2147476A1 (en) * 1992-10-20 1994-04-28 Fumie Sato Prostaglandin derivatives
US6124344A (en) * 1993-12-28 2000-09-26 Allergan Sales, Inc. Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
JP3579448B2 (ja) 1993-12-29 2004-10-20 大正製薬株式会社 プロスタグランジン誘導体、その塩およびその使用
JP3573482B2 (ja) 1994-03-07 2004-10-06 大正製薬株式会社 プロスタグランジン誘導体およびその使用
JP3506485B2 (ja) 1994-04-19 2004-03-15 大正製薬株式会社 プロスタグランジン誘導体
US5807892A (en) 1994-09-30 1998-09-15 Alcon Laboratories, Inc. Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
WO1996016935A1 (fr) 1994-11-30 1996-06-06 Taisho Pharmaceutical Co., Ltd. Derive de prostaglandines
JPH0971539A (ja) 1995-09-08 1997-03-18 Mochida Pharmaceut Co Ltd 外用鎮痒剤
JPH09169638A (ja) 1995-10-18 1997-06-30 Sekisui Chem Co Ltd 皮膚疾患治療用外用剤
US5599838A (en) * 1996-02-23 1997-02-04 Taisho Pharmaceutical Co., Ltd. Prostaglandin derivatives
JPH09286775A (ja) 1996-04-24 1997-11-04 Taisho Pharmaceut Co Ltd プロスタグランジン誘導体
WO1997045114A1 (en) 1996-05-30 1997-12-04 Lysis Corporation The treatment of vascular disease with prostaglandins via a sustained-release dermal patch
CA2275663C (en) 1996-12-23 2008-03-18 Robin Kenneth Stewart Phillips Pharmaceutical compositions comprising .alpha.-adrenergic agonists for the treatment of fecal incontinence
NO317155B1 (no) * 1997-02-04 2004-08-30 Ono Pharmaceutical Co <omega>-cykloalkyl-prostagladin-E<N>2</N>-derivater
JPH10316564A (ja) 1997-05-21 1998-12-02 Sekisui Chem Co Ltd 鎮痒鎮痛外用剤
JPH1180031A (ja) 1997-07-14 1999-03-23 Sekisui Chem Co Ltd 外用剤及び経皮又は経粘膜吸収性を増進する方法
JPH11199478A (ja) 1998-01-05 1999-07-27 Hiroshi Nagoshi レチノイド並びにプロスタグランジンｄ▲２▼誘導体の抗炎症薬としての使用
EP1082961B1 (de) * 1998-05-25 2006-01-25 Taisho Pharmaceutical Co., Ltd Schlafmittel enhaltend prostaglandinderivate
CA2333868A1 (en) 1998-06-03 1999-12-09 Shionogi & Co., Ltd. Pharmaceutical compositions for the treatment of itching comprising pgd2 receptors antagonists
US6506789B2 (en) * 1998-06-03 2003-01-14 Shionogi & Co., Ltd. Methods for the treatment of itching comprising administering PGD2 receptor antagonist
TWI249520B (en) * 1998-07-15 2006-02-21 Ono Pharmaceutical Co 5-Thia-omega-substituted phenyl prostaglandin E derivatives, method for producing the same and medicines containing the same as the active ingredient
DE69932180T2 (de) 1998-11-23 2007-06-14 Proteome Sciences, Inc., Houston Verfahren und zusammensetzungen zur schmerzbehandlung
US6191154B1 (en) 1998-11-27 2001-02-20 Case Western Reserve University Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases
JP2000273083A (ja) 1999-03-19 2000-10-03 Taisho Pharmaceut Co Ltd プロスタグランジン誘導体
JP2001089443A (ja) 1999-07-19 2001-04-03 Taisho Pharmaceut Co Ltd プロスタグランジン誘導体
DE60043702D1 (de) 1999-09-10 2010-03-04 Taisho Pharmaceutical Co Ltd Prostaglandin-derivate
JP2003509419A (ja) 1999-09-14 2003-03-11 メルク フロスト カナダ アンド カンパニー カルボン酸類およびアシルスルホンアミド類、そのような化合物を含む組成物、ならびに治療方法
JP2001122786A (ja) 1999-10-20 2001-05-08 Taisho Pharmaceut Co Ltd 睡眠誘発剤
JP2001151749A (ja) 1999-11-24 2001-06-05 Taisho Pharmaceut Co Ltd プロスタグランジン誘導体
EP1308162A1 (de) * 1999-11-24 2003-05-07 Taisho Pharmaceutical Co., Ltd Pernasale zusammensetzung
AU2227401A (en) 2000-01-05 2001-07-16 Ono Pharmaceutical Co. Ltd. 5-thia-omega-(substituted phenyl)-prostaglandin e alcohols, process for preparing the alcohols and pharmaceutical preparations containing the same as the activeingredient
JP2001220355A (ja) 2000-02-07 2001-08-14 Teijin Ltd ＰＰＡＲβ／δ及びγリガンドからなる肥満細胞活性化抑制剤
US6878522B2 (en) 2000-07-07 2005-04-12 Baiyong Li Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2
US6835752B2 (en) * 2000-08-22 2004-12-28 Ono Pharmaceutical Co., Ltd. Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient
WO2002020462A1 (fr) 2000-09-01 2002-03-14 Ono Pharmaceutical Co., Ltd. Derives d'acide benzoique et medicaments possedant ces derniers comme principe actif
AU2002229611A1 (en) 2000-12-08 2002-06-18 Institut National De La Sante Et De La Recherche Medicale (Inserm) Use of active compounds capable of modulating the intracellular pathway triggered by the dp receptor in langerhans cells
WO2003070252A1 (fr) 2002-02-22 2003-08-28 Taisho Pharmaceutical Co., Ltd. Agents antiprurigineux
US20040266880A1 (en) * 2002-02-22 2004-12-30 Fumie Sato Antipruritics
US7737182B2 (en) * 2002-08-09 2010-06-15 Taisho Pharmaceutical Co., Ltd. Pharmaceuticals for xerosis
JP3678366B2 (ja) 2002-08-09 2005-08-03 大正製薬株式会社 止痒剤

Also Published As

Publication number Publication date
CN1620297A (zh) 2005-05-25
CN100408039C (zh) 2008-08-06
CA2465103A1 (en) 2004-02-19
EP1527781B1 (de) 2008-07-23
PT1527781E (pt) 2008-08-12
TWI328574B (de) 2010-08-11
EP1527781A4 (de) 2006-12-13
CA2465103C (en) 2011-04-26
JP3678366B2 (ja) 2005-08-03
WO2004014394A1 (ja) 2004-02-19
MXPA04004371A (es) 2004-08-13
EP1527781A1 (de) 2005-05-04
PL373819A1 (en) 2005-09-19
AU2003254850B2 (en) 2008-05-15
ES2309380T3 (es) 2008-12-16
HK1076391A1 (en) 2006-01-20
NO20042053L (no) 2004-05-18
ATE401895T1 (de) 2008-08-15
US20050009917A1 (en) 2005-01-13
US7718701B2 (en) 2010-05-18
KR100904583B1 (ko) 2009-06-25
KR20050026375A (ko) 2005-03-15
AU2003254850A1 (en) 2004-02-25
JPWO2004014394A1 (ja) 2005-12-02
DK1527781T3 (da) 2008-11-17
TW200404053A (en) 2004-03-16

Similar Documents

Publication Publication Date Title
TNSN06138A1 (fr) Inhibitors of the mutant form of kit
DK1485360T3 (da) Natriumkanalblokkere
ATE504315T1 (de) Methode für die ausarbeitung von cd10-aktivierten prodrug-verbindungen
CY1105994T1 (el) Aναδιαταγμενες πεντανολες, μεθοδος για την παραγωγη αυτων και η χρηση αυτων ως αντιφλεγμονωδων
IS2696B (is) Setin 2-amínótetralín fyrir meðhöndlunina á geðdeyfð
EA200600465A1 (ru) Ингибиторы каспазы, содержащие изоксазолиновый цикл
EA200600621A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
EA200600197A1 (ru) Получение производных соединения 1,3-дифенилпроп-2-ен-1-он
CY1108221T1 (el) Μεθοδος για την αναπαραγωγη πλευρομουτιλινων
NO20053042L (no) Anvendelse av spongosin (2-metoksyadenosin) for behandling av smerte, saerlig hyperalgesi.
BRPI0716643A2 (pt) amidas terapêuticas e compostos relacionados
ATE202483T1 (de) Immuntolerante prothrombinkomplex-präparation
DK1458393T3 (da) Substituerede diketopiperaziner som oxytocinantagonister
TR200401028T2 (tr) Kistik fibrozun tedavisine yönelik metot
ECSP044985A (es) Azitromicina de dosis única para infecciones respiratorias
DE60322395D1 (de) Antipruritisches mittel
NO20072668L (no) Ny kombinasjon
DE60329326D1 (de) Tace inhibitoren
UA87822C2 (ru) Производные нафтилена как ингибиторы цитохрома p450
SE0200198D0 (sv) New use
DE602005011267D1 (de) Benzofuran- und benzothiophenderivate, die sich für die behandlung von herzkreislauferkrankungen eignen
EA200700550A1 (ru) Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
SE0301883D0 (sv) New use II
CY1112457T1 (el) Χρωμανο- και θειοxρωμανο-3-υλο-1,3-διυδρο-ιμιδαζολια ως αναστολεις της ντοπαμινο-β-υδροξυλασης, και μεθοδοι παρασκευης αυτων
DK1638948T3 (da) Diphenylurinstofderivater og deres anvendelse som chloridkanalblokkere

Legal Events

Date Code Title Description
8364 No opposition during term of opposition